205 related articles for article (PubMed ID: 30132974)
21. USP8 suppresses death receptor-mediated apoptosis by enhancing FLIP
Jeong M; Lee EW; Seong D; Seo J; Kim JH; Grootjans S; Kim SY; Vandenabeele P; Song J
Oncogene; 2017 Jan; 36(4):458-470. PubMed ID: 27321185
[TBL] [Abstract][Full Text] [Related]
22. Reciprocal cross-regulation between RNF41 and USP8 controls cytokine receptor sorting and processing.
De Ceuninck L; Wauman J; Masschaele D; Peelman F; Tavernier J
J Cell Sci; 2013 Aug; 126(Pt 16):3770-81. PubMed ID: 23750007
[TBL] [Abstract][Full Text] [Related]
23. Cushing's disease due to somatic USP8 mutations: a systematic review and meta-analysis.
Wanichi IQ; de Paula Mariani BM; Frassetto FP; Siqueira SAC; de Castro Musolino NR; Cunha-Neto MBC; Ochman G; Cescato VAS; Machado MC; Trarbach EB; Bronstein MD; Fragoso MCBV
Pituitary; 2019 Aug; 22(4):435-442. PubMed ID: 31273566
[TBL] [Abstract][Full Text] [Related]
24. USP8 Mutations and Cell Cycle Regulation in Corticotroph Adenomas.
Martins CS; Camargo RC; Coeli-Lacchini FB; Saggioro FP; Moreira AC; de Castro M
Horm Metab Res; 2020 Feb; 52(2):117-123. PubMed ID: 32053843
[TBL] [Abstract][Full Text] [Related]
25. USP8 mutations in corticotroph adenomas determine a distinct gene expression profile irrespective of functional tumour status.
Bujko M; Kober P; Boresowicz J; Rusetska N; Paziewska A; Dąbrowska M; Piaścik A; Pękul M; Zieliński G; Kunicki J; Bonicki W; Ostrowski J; Siedlecki JA; Maksymowicz M
Eur J Endocrinol; 2019 Dec; 181(6):615-627. PubMed ID: 31581124
[TBL] [Abstract][Full Text] [Related]
26. Recurrent gain-of-function USP8 mutations in Cushing's disease.
Ma ZY; Song ZJ; Chen JH; Wang YF; Li SQ; Zhou LF; Mao Y; Li YM; Hu RG; Zhang ZY; Ye HY; Shen M; Shou XF; Li ZQ; Peng H; Wang QZ; Zhou DZ; Qin XL; Ji J; Zheng J; Chen H; Wang Y; Geng DY; Tang WJ; Fu CW; Shi ZF; Zhang YC; Ye Z; He WQ; Zhang QL; Tang QS; Xie R; Shen JW; Wen ZJ; Zhou J; Wang T; Huang S; Qiu HJ; Qiao ND; Zhang Y; Pan L; Bao WM; Liu YC; Huang CX; Shi YY; Zhao Y
Cell Res; 2015 Mar; 25(3):306-17. PubMed ID: 25675982
[TBL] [Abstract][Full Text] [Related]
27. Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma.
Kim Y; Shiba-Ishii A; Nakagawa T; Iemura SI; Natsume T; Nakano N; Matsuoka R; Sakashita S; Lee S; Kawaguchi A; Sato Y; Noguchi M
Oncogene; 2018 Oct; 37(40):5387-5402. PubMed ID: 29880877
[TBL] [Abstract][Full Text] [Related]
28. Regulation of ubiquitin-specific processing protease 8 suppresses neuroinflammation.
Zhu L; Bi W; Lu D; Zhang C; Shu X; Wang H; Qi R; Shi Q; Lu D
Mol Cell Neurosci; 2015 Jan; 64():74-83. PubMed ID: 24861766
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin-specific protease 8 (USP8/UBPy): a prototypic multidomain deubiquitinating enzyme with pleiotropic functions.
Dufner A; Knobeloch KP
Biochem Soc Trans; 2019 Dec; 47(6):1867-1879. PubMed ID: 31845722
[TBL] [Abstract][Full Text] [Related]
30. Molecular basis of ubiquitin-specific protease 8 autoinhibition by the WW-like domain.
Kakihara K; Asamizu K; Moritsugu K; Kubo M; Kitaguchi T; Endo A; Kidera A; Ikeguchi M; Kato A; Komada M; Fukushima T
Commun Biol; 2021 Nov; 4(1):1272. PubMed ID: 34750505
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer.
He M; Hu C; Deng J; Ji H; Tian W
World J Surg Oncol; 2021 Oct; 19(1):294. PubMed ID: 34600547
[TBL] [Abstract][Full Text] [Related]
32. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
33. USP8: a novel therapeutic target for Cushing's disease.
Jian F; Cao Y; Bian L; Sun Q
Endocrine; 2015 Nov; 50(2):292-6. PubMed ID: 26162929
[TBL] [Abstract][Full Text] [Related]
34. Identification of a 4-mRNA metastasis-related prognostic signature for patients with breast cancer.
Xie X; Wang J; Shi D; Zou Y; Xiong Z; Li X; Zhou J; Tang H; Xie X
J Cell Mol Med; 2019 Feb; 23(2):1439-1447. PubMed ID: 30484951
[TBL] [Abstract][Full Text] [Related]
35. Germline USP8 Mutation Associated With Pediatric Cushing Disease and Other Clinical Features: A New Syndrome.
Cohen M; Persky R; Stegemann R; Hernández-Ramírez LC; Zeltser D; Lodish MB; Chen A; Keil MF; Tatsi C; Faucz FR; Buchner DA; Stratakis CA; Tiosano D
J Clin Endocrinol Metab; 2019 Oct; 104(10):4676-4682. PubMed ID: 31162547
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
[TBL] [Abstract][Full Text] [Related]
37. Deubiquitylation and stabilization of Notch1 intracellular domain by ubiquitin-specific protease 8 enhance tumorigenesis in breast cancer.
Shin S; Kim K; Kim HR; Ylaya K; Do SI; Hewitt SM; Park HS; Roe JS; Chung JY; Song J
Cell Death Differ; 2020 Apr; 27(4):1341-1354. PubMed ID: 31527799
[TBL] [Abstract][Full Text] [Related]
38. USP8 and TP53 Drivers are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors.
Uzilov AV; Taik P; Cheesman KC; Javanmard P; Ying K; Roehnelt A; Wang H; Fink MY; Lau CY; Moe AS; Villar J; Bederson JB; Stewart AF; Donovan MJ; Mahajan M; Sebra R; Post KD; Chen R; Geer EB
J Clin Endocrinol Metab; 2021 Mar; 106(3):826-842. PubMed ID: 33221858
[TBL] [Abstract][Full Text] [Related]
39. Biophysical and structural insight into the USP8/14-3-3 interaction.
Centorrino F; Ballone A; Wolter M; Ottmann C
FEBS Lett; 2018 Apr; 592(7):1211-1220. PubMed ID: 29473952
[TBL] [Abstract][Full Text] [Related]
40. Usp8 promotes tumor cell migration through activating the JNK pathway.
Zhao Y; Peng D; Liu Y; Zhang Q; Liu B; Deng Y; Ding W; Zhou Z; Liu Q
Cell Death Dis; 2022 Mar; 13(3):286. PubMed ID: 35361778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
